Organization | Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines

Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2008

NCT00708084

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Alternative names

Research Institute for Tropical Medicine, Philippines | Research Institute for Tropical Medicine(RITM) FCC, Alabang, Muntinlupa city, Philippines, 1781

Active Ingredients

Drugs in Phase 2 Trials (5)

foravirumab (1 trial)

inactivated influenza vaccine (1 trial)

rabies immune globulin (human) (HyperRAB) (1 trial)

sodium chloride (1 trial)

vi-dt typhoid conjugate vaccine (1 trial)

Drugs in Other Trials (3)

artemether (1 trial)

chloroquine (1 trial)

lumefantrine (Coartem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Rabies (Phase 2)

Typhoid Fever (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 8